Back to Guavy Wire

Stocks

RBC Capital Analyst Upgrades Eli Lilly & Co to Buy

Guavy AI Editorial Team Published October 4, 2026

Instruments

MRK

RBC Capital analyst Trung Huynh has maintained a Buy rating on Eli Lilly & Co (LLY) and set a price target of $1,500.00.

The current share price is at $1,149.85, which is below the estimated value according to Huynh's prediction.

Huynh covers the Healthcare sector, focusing on stocks like Bristol-Myers Squibb and Merck & Company, among others.

According to TipRanks, Huynh has an average return of 22.2% and a success rate of 76.51% on recommended stocks.

More on Stocks

Stocks 4m ago

Amazon's Prime Big Deal Days 2026 Ends Soon: Top Deals to Snap Up

Stocks 4m ago

Amazon Slashes Prices on HeyDude Slip-On Shoes by Up to 50%

Stocks 4m ago

Amazon Pledges $1 Billion to Communities Hosting Data Centers Amid AI Expansion

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy